12 results on '"Hibbert MP"'
Search Results
2. Managing chronic kidney disease in a nurse-run, physician-monitored clinic: the CanPREVENT experience.
- Author
-
Molzahn AE, Hibbert MP, Gaudet D, Starzomski R, Barrett B, and Morgan J
- Published
- 2008
3. Service provision and barriers to care for men who have sex with men engaging in chemsex and sexualised drug use in the North and West Midlands of England
- Author
-
Hibbert, MP, Germain, J, Brett, CE, Van Hout, MC, Hope, V, and Porcellato, LA
- Subjects
RA0421 - Abstract
Background: Chemsex and sexualised drug use (SDU) among men who have sex with men 6 (MSM) has become a public health issue because of its associated sexual risks. Some MSM 7 engaging in SDU require further help and support, but it is not clear if this need is being met. 8 This research seeks to understand MSM and service provider (SP) perspectives of the current 9 standard of service provision for MSM engaging in SDU. 10 Method: Semi-structured interviews were conducted with 13 MSM and 16 SPs in England 11 (January-December 2019). MSM who reported taking one of ten substances for sex in the 12 past 12 months were recruited from a mailing list or a community organisation providing 13 chemsex support. Potential SP participants were recruited via an email sent from their local 14 healthcare NHS Trust. Data for MSM and SPs were analysed separately using thematic 15 analysis. 16 Results: MSM participants had a median age of 34 years (range 23-66). The majority of SPs 17 recruited were genitourinary medicine (GUM) consultants. We found that the main reason for 18 engagement in SDU was because of the enhanced sexual experience. Most MSM recruited 19 were satisfied with their sexual health service provision, but barriers to care were highlighted 20 by both MSM and SPs. Four themes relating to barriers to care were identified: accessibility 21 of sexual health services, funding of services, SP’s attitudes towards MSM who engage in 22 SDU, and services outside sexual healthcare. 3 1 Conclusion: SPs appeared to have adopted a harm reduction approach to MSM engaging in 2 SDU, but for MSM wanting further help and assistance in relation to their SDU additional 3 barriers to care existed. Training healthcare providers outside of sexual health services 4 regarding chemsex and SDU may reduce some of these barriers, but funding for sexual health 5 services needs to be improved to maintain and further develop services.
4. A rapid review of antenatal hepatitis C virus testing in the United Kingdom.
- Author
-
Hibbert MP, Simmons R, Mandal S, Sabin CA, and Desai M
- Subjects
- Humans, Female, Pregnancy, Prenatal Diagnosis, Cost-Benefit Analysis, RNA, United Kingdom, Hepacivirus, Hepatitis C diagnosis, Hepatitis C epidemiology
- Abstract
Background: The United Kingdom (UK) has committed to the World Health Organization's viral hepatitis elimination targets. New case finding strategies, such as antenatal testing, may be needed to achieve these targets. We conducted a rapid review to understand hepatitis C-specific antibody (anti-HCV) and HCV RNA test positivity in antenatal settings in the United Kingdom to inform guidance., Methods: Articles and conference abstracts published between January 2000 and June 2022 reporting anti-HCV testing in antenatal settings were identified through PubMed and Web of Science searches. Results were synthesised using a narrative approach., Results: The search identified 2,011 publications; 10 studies were included in the final synthesis. Seven studies used anonymous testing methods and three studies used universal opt-out testing. Anti-HCV test positivity ranged from 0.1 to 0.99%, with a median value of 0.38%. Five studies reported HCV RNA positivity, which ranged from 0.1 to 0.57% of the testing population, with a median value of 0.22%. One study reported cost effectiveness of HCV and found it to be cost effective at £9,139 per quality adjusted life years., Conclusion: The relative contribution of universal opt-out antenatal testing for HCV should be reconsidered, as antenatal testing could play an important role in new case-finding and aid achieving elimination targets., (© 2023. Crown.)
- Published
- 2023
- Full Text
- View/download PDF
5. Image and performance enhancing drug use among men who have sex with men and women who have sex with women in the UK.
- Author
-
Hibbert MP, Brett CE, Porcellato LA, and Hope VD
- Subjects
- Female, Homosexuality, Male, Humans, Male, Sexual Behavior, United Kingdom epidemiology, Performance-Enhancing Substances, Sexual and Gender Minorities
- Abstract
Background: The use of image and performance enhancing drugs (IPEDs) among men who have sex with men (MSM) and women who have sex with women (WSW) is rarely studied, with most of this research focused on anabolic androgenic steroid use among MSM. To address this gap, the extent of recent IPED use and the associated factors are explored in a community-recruited sample of MSM and WSW METHODS: Data from the UK LGBT Sex and Lifestyles Survey was used, which recruited through social-media advertising and community organisations (April-June 2018). Participants were asked if they had taken any IPEDs (e.g. anabolic steroids, growth hormone, hCG, Melanotan, non-prescribed diet pills) in the past 12 months. Factors associated with recent (in past 12 months) IPED use among MSM and WSW were investigated using stepwise binary logistic regression., Results: 1,658 MSM and 1,507 WSW were included in the analysis. Among MSM, 3.4% (n = 57) had recently taken IPEDs, 60% of those taking IPEDs had used psychoactive drugs. In the multivariable analysis, IPED use among MSM was associated with psychoactive drug use, Viagra use, higher body dissatisfaction, and lower sexual satisfaction. Among WSW, 4.1% (n = 62) had recently taken IPEDs, and 50% of those taking IPEDs had used psychoactive drugs. In the multivariable analysis, IPED use among WSW was associated with being aged 45 years and over, recent STI diagnosis, recent sexual contact without consent, and higher body dissatisfaction., Conclusion: IPED use was reported by around 1-in-25 MSM and WSW, and was associated with a number of health and psychological problems. Research to better understand the drivers and impacts of IPED use among MSM and WSW, and how this compares to use among heterosexual people is needed., Competing Interests: Declarations of Interest None., (Copyright © 2020 Elsevier B.V. All rights reserved.)
- Published
- 2021
- Full Text
- View/download PDF
6. A narrative systematic review of sexualised drug use and sexual health outcomes among LGBT people.
- Author
-
Hibbert MP, Hillis A, Brett CE, Porcellato LA, and Hope VD
- Subjects
- Cross-Sectional Studies, Female, Homosexuality, Male, Humans, Male, Outcome Assessment, Health Care, Sexual Behavior, HIV Infections epidemiology, Pharmaceutical Preparations, Sexual and Gender Minorities, Substance-Related Disorders epidemiology
- Abstract
Introduction: Chemsex is a specific form of sexualised drug use (SDU) that is an emerging public health issue among men who have sex with men (MSM). Although the recent focus on chemsex is a reflection of the associated harms it is important to understand SDU more broadly and its associations with risk behaviours. Additionally, some of the reasons suggested for MSM engagement in SDU are also likely to apply to women who have sex with women (WSW) and trans people. The aim of this review was to investigate SDU, including chemsex, among lesbian, gay, bisexual and trans (LGBT) people internationally in relation to sexual health outcomes (HIV status, STI diagnosis, condom use)., Methods: Papers that were published between January 2010 and June 2020 reporting SDU in MSM, WSW, or trans people were identified through Medline, PsycINFO, CINAHL Plus and Web of Science. Results were synthesised using a narrative approach., Results: The search identified 2,710 publications, of which 75 were included in the final synthesis. The majority of studies measured SDU among MSM (n = 71), and four studies measured SDU among trans people. Research into SDU had been conducted in 55 countries and 32 countries had recorded the use of a chemsex drug among MSM, although the drugs used to define chemsex varied. Among studies that researched MSM, SDU was most commonly investigated in relation to condomless anal intercourse (n = 42), followed by HIV prevalence (n = 35), and then STI diagnoses (n = 27). Drug use was generally associated with sexual health outcomes, but particularly in chemsex studies., Conclusions: SDU research is lacking among WSW and trans people, despite trans women having a high HIV prevalence. Among MSM, most drugs were associated with sexual health outcomes, and therefore it is important to include both chemsex drugs and other drugs in SDU research., Competing Interests: Declarations of Interest We wish to confirm that there are no known conflicts of interest associated with this publication and there has been no significant financial support for this work that could have influenced its outcome., (Copyright © 2021 Elsevier B.V. All rights reserved.)
- Published
- 2021
- Full Text
- View/download PDF
7. "Belt and braces approach; added benefit and … extra reassurance": a multi-stakeholder examination of the challenges to effective provision of pre-exposure prophylaxis (PrEP) for HIV prevention among men who have sex with men (MSM) in Northern and Central England.
- Author
-
Hillis A, Germain J, Hibbert MP, Hope V, and Van Hout MC
- Subjects
- Cities, England, Homosexuality, Male, Humans, Male, Anti-HIV Agents therapeutic use, HIV Infections drug therapy, HIV Infections prevention & control, Pre-Exposure Prophylaxis, Sexual and Gender Minorities
- Abstract
Pre-exposure prophylaxis (PrEP) involves HIV negative individuals taking antiretroviral drugs to reduce the probability of infection if exposed and is available through the IMPACT trial in England. This study aimed to explore men who have sex with men (MSM) and service provider (SP) perspectives on provision and accessibility of PrEP in Northern and Central England. Twenty MSM and 25 SPs from four Northern cities and one city in the West Midlands region were recruited for semi-structured interviews (December 2018 to October 2019). Interviews were analysed using Interpretative Phenomenological Analysis (IPA). Three key themes emerged: "Self-sourcing PrEP"; "Service delivery learnings"; and "Impact of using PrEP". Problems with equity of access and accessibility were noted, and recommendations for the future of PrEP programming and equitable service delivery were also presented. The study highlighted divergence in PrEP service experience from patients and providers, with results informing policy, practice and professional training.
- Published
- 2021
- Full Text
- View/download PDF
8. Service provision and barriers to care for men who have sex with men engaging in chemsex and sexualised drug use in England.
- Author
-
Hibbert MP, Germain JS, Brett CE, Van Hout MC, Hope VD, and Porcellato LA
- Subjects
- Adult, Aged, Cross-Sectional Studies, England, Health Services Accessibility, Homosexuality, Male, Humans, Male, Middle Aged, Sexual Behavior, Young Adult, HIV Infections, Pharmaceutical Preparations, Sexual and Gender Minorities, Substance-Related Disorders
- Abstract
Background: Chemsex and sexualised drug use (SDU) among men who have sex with men (MSM) has become a public health issue because of its associated sexual risks. Some MSM engaging in SDU require further help and support, but it is not clear if this need is being met. This research seeks to understand MSM and service provider (SP) perspectives of the current standard of service provision for MSM engaging in SDU., Method: Semi-structured interviews were conducted with 13 MSM and 16 SPs in England (January-December 2019). MSM who reported taking one of ten substances for sex in the past 12 months were recruited from a mailing list or a community organisation providing chemsex support. Potential SP participants were recruited via an email sent from their local healthcare NHS Trust. Data for MSM and SPs were analysed separately using thematic analysis., Results: MSM participants had a median age of 34 years (range 23-66).The majority of SPs recruited were genitourinary medicine (GUM) consultants. We found that the main reason for engagement in SDU was because of the enhanced sexual experience. Most MSM recruited were satisfied with their sexual health service provision, but barriers to care were highlighted by both MSM and SPs. Four themes relating to barriers to care were identified: accessibility of sexual health services, funding of services, SP's attitudes towards MSM who engage in SDU, and services outside sexual healthcare., Conclusion: SPs appeared to have adopted a harm reduction approach to MSM engaging in SDU, but for MSM wanting further help and assistance in relation to their SDU additional barriers to care existed. Training healthcare providers outside of sexual health services regarding chemsex and SDU may reduce some of these barriers, but funding for sexual health services needs to be improved to maintain and further develop services., Competing Interests: Declarations of Interest None., (Copyright © 2020. Published by Elsevier B.V.)
- Published
- 2021
- Full Text
- View/download PDF
9. Psychosocial and sexual factors associated with recent sexual health clinic attendance and HIV testing among trans people in the UK.
- Author
-
Hibbert MP, Wolton A, Weeks H, Ross M, Brett CE, Porcellato LA, and Hope VD
- Subjects
- Adolescent, Adult, Cross-Sectional Studies, Female, HIV Infections epidemiology, Humans, Male, Mass Screening methods, Mass Screening standards, Mass Screening statistics & numerical data, Middle Aged, Reproductive Health Services standards, Reproductive Health Services statistics & numerical data, Surveys and Questionnaires, Transgender Persons statistics & numerical data, United Kingdom epidemiology, HIV Infections diagnosis, Psychology statistics & numerical data, Sex Factors, Transgender Persons psychology
- Abstract
Objectives: Trans people remain an understudied population in the UK, with unmet sexual health needs. The aim of this research was to identify possible barriers and facilitators for sexual health clinic attendance and HIV testing among trans people., Methods: Lesbian, gay, bisexual and transgender (LGBT) participants from across the UK were invited to take part in a cross-sectional online survey through Facebook advertising (April-June 2018). Psychosocial and sexual factors associated with recent sexual health clinic attendance, and ever having an HIV test were examined using multivariate logistic regression., Results: A total of 3007 cisgender and 500 trans participants completed the survey. Trans participants were less likely to attend a sexual health clinic than cisgender participants (27% vs 36%, p<0.001) and report ever having an HIV test (49% vs 64%, p<0.001). One trans participant reported living with HIV and three reported currently taking pre-exposure prophylaxis. Factors associated with trans sexual health clinic attendance were: living in London, having a relationship with multiple partners, engaging in condomless anal intercourse, greater life satisfaction, and having alcohol and/or drugs before sex. Being a person of colour, aged 25-49 years, in a relationship with multiple partners, condomless anal intercourse, lower body dissatisfaction, and having drugs before sex were associated with ever having an HIV test among trans participants., Conclusions: Trans people were less likely to attend sexual health services than cisgender people, and half of trans participants who reported condomless anal intercourse had never had an HIV test. Further research is needed to understand and improve uptake of sexual health services among trans people., Competing Interests: Competing interests: None declared., (© Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ.)
- Published
- 2020
- Full Text
- View/download PDF
10. Sexually transmitted infection diagnoses, sexualised drug use and associations with pre-exposure prophylaxis use among men who have sex with men in the UK.
- Author
-
Hibbert MP, Brett CE, Porcellato LA, and Hope VD
- Subjects
- Adult, Cross-Sectional Studies, Homosexuality, Male statistics & numerical data, Humans, Male, Risk-Taking, Sexual Behavior, Sexual Partners, Sexually Transmitted Diseases prevention & control, Sexually Transmitted Diseases psychology, Substance-Related Disorders, Condoms statistics & numerical data, Homosexuality, Male psychology, Pre-Exposure Prophylaxis, Sexually Transmitted Diseases epidemiology
- Published
- 2020
- Full Text
- View/download PDF
11. Associations with drug use and sexualised drug use among women who have sex with women (WSW) in the UK: Findings from the LGBT Sex and Lifestyles Survey.
- Author
-
Hibbert MP, Porcellato LA, Brett CE, and Hope VD
- Subjects
- Adult, Age Factors, Bisexuality statistics & numerical data, Cross-Sectional Studies, Female, Humans, Sexual Partners, Surveys and Questionnaires, United Kingdom epidemiology, Young Adult, Homosexuality, Female statistics & numerical data, Sexual Behavior statistics & numerical data, Sexual and Gender Minorities statistics & numerical data, Substance-Related Disorders epidemiology
- Abstract
Introduction: Studies indicate that women who have sex with women (WSW) report greater levels of drug use than heterosexual women, but globally few studies have looked at sexualised drug use among WSW. This study investigated the factors associated with drug use and sexualised drug use (SDU) among WSW., Methods: Potential participants across the UK were invited to take part in a cross-sectional anonymous online survey between April-June 2018. The LGBT Sex and Lifestyles Survey recruited participants through Facebook advertising and social media posts from community organisations. Multivariate logistic regression was used to compare WSW who had engaged in any drug use in the past 12 months with those who had not, and those who engaged in sexualised drug use in the past 12 months with those who engaged in other drug use., Results: 1501 WSW could be included in the analyses (mean age = 28.9, 97% white ethnicity). Any drug use was reported by 39% of WSW (n = 583), 44% of which (17% of total, n = 258) reported SDU. Factors associated with drug use were identifying as queer (aOR = 1.86, 95%CI 1.08, 3.23), younger age (aOR = 0.96, 95%CI 0.95, 0.98), being born outside the UK (aOR = 1.75, 95%CI 1.15, 2.66), recent sexual assault (aOR = 2.35, 95%CI 1.43, 3.86), > = 5 female sexual partners (aOR = 3.81, 95%CI 1.81, 8.01), and psychological distress (aOR = 1.75, 95%CI 1.15, 2.67). SDU was associated with identifying as bisexual (aOR = 2.55, 95%CI 1.69, 3.86), > = 5 female sexual partners (aOR = 4.50, 95%CI 1.91, 10.59), and highest education achieved at 16 or lower (aOR = 2.46, 95%CI 1.24, 4.90)., Conclusions: Some WSW may have negative experiences in relation to drug use and SDU. Harm reduction and health services that provide services for WSW should be aware of potentially compounding factors related to drug use, such as sexual assault and psychological distress, providing a safe and LGBT-friendly environment to discuss these issues., (Copyright © 2019 Elsevier B.V. All rights reserved.)
- Published
- 2019
- Full Text
- View/download PDF
12. Psychosocial and sexual characteristics associated with sexualised drug use and chemsex among men who have sex with men (MSM) in the UK.
- Author
-
Hibbert MP, Brett CE, Porcellato LA, and Hope VD
- Subjects
- Adult, Cross-Sectional Studies, Harm Reduction, Humans, Illicit Drugs adverse effects, Male, Middle Aged, Psychology, Substance-Related Disorders psychology, United Kingdom epidemiology, Young Adult, Sexual and Gender Minorities psychology, Sexual and Gender Minorities statistics & numerical data, Substance-Related Disorders epidemiology, Unsafe Sex psychology, Unsafe Sex statistics & numerical data
- Abstract
Objective: To understand how the emerging public health issue of chemsex relates to broader patterns of sexualised drug use (SDU) among men who have sex with men (MSM), which has been understudied., Methods: Potential participants were invited to take part in an anonymous, cross-sectional online survey through Facebook advertising and community organisations' social media posts (April-June 2018). Multivariable logistic regression was used to compare MSM who engaged in recent SDU (past 12 months) with those who did not, and those who engaged in chemsex (γ-hydroxybutyrate/γ-butyrolactone, crystal methamphetamine, mephedrone, ketamine) with those who engaged in other SDU (eg, poppers, cocaine, cannabis)., Results: Of the 1648 MSM included, 41% reported recent SDU; 15% of these (6% of total, n=99) reported chemsex. Factors associated with SDU were recent STI diagnosis (aOR=2.44, 95% CI 1.58 to 3.76), sexual health clinic attendance (aOR=2.46, 95% CI 1.90 to 3.20), image and performance-enhancing drug use (aOR=3.82, 95% CI 1.87 to 7.82), greater number of condomless anal male partners, lower satisfaction with life and greater sexual satisfaction. Predictors of chemsex compared with other SDU were not being UK-born (aOR=2.02, 95% CI 1.05 to 3.86), living in a densely populated area (aOR=2.69, 95% CI 1.26 to 5.74), low sexual self-efficacy (aOR=4.52, 95% CI 2.18 to 9.40) and greater number of condomless anal male partners. Living with HIV, taking pre-exposure prophylaxis (PrEP), and experiencing or being unsure of experiencing sexual contact without consent were significantly associated with SDU and chemsex in bivariate analyses but not in the multivariable., Conclusion: Health and behavioural differences were observed between MSM engaging in chemsex, those engaging in SDU and those engaging in neither. While some MSM engaging in chemsex and SDU appeared content with these behaviours, the association with life satisfaction and sexual self-efficacy indicates psychosocial support is needed for some. The association with sexual risk and sexual consent also indicates the importance of promoting harm reduction among this population (eg, condoms, PrEP, drug knowledge)., Competing Interests: Competing interests: None declared., (© Author(s) (or their employer(s)) 2019. No commercial re-use. See rights and permissions. Published by BMJ.)
- Published
- 2019
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.